Publications

1. Rius-Sansalvador B, Chatziioannou AC, Keski-Rahkonen P, Robinot NR, Moratalla-Navarro F, Moragas N, et al. (2026). Consistent metabolomic and genetic evidence supports acisoga as a key contributor to colorectal neoplasia progression. Cancer Epidemiol Biomarkers Prev. https://doi.org/10.1158/1055-9965.EPI-25-2050 PMID:42201318
2. Yano Y, Albert PS, Roy S, Farhat Z, Baer DJ, Moore SC, et al. (2026). Semi-targeted metabolomics analysis of biomarkers of low to moderate alcohol intake in the Postmenopausal Women’s Alcohol Study: a randomized controlled crossover feeding study. J Nutr. 156(5):101488. https://doi.org/10.1016/j.tjnut.2026.101488 PMID:41871667
3. Wang SE, Viallon V, Biessy C, O’Mara T, Kyrgiou M, Ellis LB, et al. (2026). Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediators. J Natl Cancer Inst. djag119. https://doi.org/10.1093/jnci/djag119 PMID:42015885
4. Vasson F, Matta K, Biessy C, S Antoniussen C, Fournier A, Marques C, et al. (2025). Lifestyle changes and postmenopausal breast cancer risk in women from the European Prospective Investigation into Cancer and Nutrition. Breast Cancer Res. 27(1):192. https://doi.org/10.1186/s13058-025-02148-w PMID:41163053
5. Majidi A, Rinaldi S, Truong T, Dossus L, Fournier A (2026). Pre-diagnosis thyroid dysfunction and ovarian cancer risk and survival: a prospective cohort study. J Natl Cancer Inst. djag055. https://doi.org/10.1093/jnci/djag055 PMID:41706832
6. Dansero L, Milani L, Sacerdote C, Ferrari P, Jenab M, Ricceri F (2026). Exploring the syndemic of steatotic liver disease, socioeconomic inequities and cancer risk in the UK Biobank. Liver Int. 46(1):e70458. https://doi.org/10.1111/liv.70458 PMID:41324228
7. Matray C, Debras C, Chatziioannou AC, Perlemuter G, Jenab M, Voican CS (2025). Diet habits and hepatocellular carcinoma – potential implication for clinical practice. Nutr Rev. 83(12):2372–88. https://doi.org/10.1093/nutrit/nuaf129 PMID:40679550
8. Aglago EK, Ramos I, Keski-Rahkonen P, Chatziioannou C, Freisling H, Fedirko V, et al. (2025). Alcohol and smoking habits in association with hepatocellular carcinoma risk. Int J Cancer. 157(4):644–57. https://doi.org/10.1002/ijc.35401 PMID:40098437
9. His M, Gunter MJ, Keski-Rahkonen P, Rinaldi S (2024). Application of metabolomics to epidemiologic studies of breast cancer: new perspectives for etiology and prevention. J Clin Oncol. 42(1):103–15. https://doi.org/10.1200/JCO.22.02754 PMID:37944067
10. Majidi A, Rinaldi S, Biessy C, Vozar B, Truong T, Turzanski Fortner R, et al. (2025). Thyroid hormones and epithelial ovarian cancer risk and survival: results from the European Prospective Investigation into Cancer and Nutrition study. J Natl Cancer Inst. 117(11):2343–51. https://doi.org/10.1093/jnci/djaf222 PMID:40811636
11. Mayén AL, Sabra M, Aglago EK, Perlemuter G, Voican C, Ramos I, et al. (2024). Hepatic steatosis, metabolic dysfunction and risk of mortality: findings from a multinational prospective cohort study. BMC Med. 22(1):221. https://doi.org/10.1186/s12916-024-03366-3 PMID:38825687
12. Daniel N, Genua F, Jenab M, Mayén AL, Chrysovalantou Chatziioannou A, Keski-Rahkonen P, et al. (2024). The role of the gut microbiome in the development of hepatobiliary cancers. Hepatology. 80(5):1252–69. https://doi.org/10.1097/HEP.0000000000000406 PMID:37055022
13. Berden J, Chimera B, Hanley-Cook GT, Cakmak EK, Vineis P, Nicolas G, et al. (2025). Biodiverse diets present co-benefits for greenhouse gas emissions, land use, mortality rates and nutritional adequacy in Europe. Nat Food. 6(9):857–67. https://doi.org/10.1038/s43016-025-01214-y PMID:40835792
14. Stein MJ, Freisling H, Leitzmann MF (2025). Clinical obesity and all-cause and cause-specific mortality in UK Biobank. JAMA Intern Med. 185(12):1497–500. https://doi.org/10.1001/jamainternmed.2025.4978 PMID:41143828
15. Córdova R, Kim J, Thompson AS, Noh H, Shah S, Dahm CC, et al. (2025). Plant-based dietary patterns and age-specific risk of multimorbidity of cancer and cardiometabolic diseases: a prospective analysis. Lancet Healthy Longev. 6(8):100742. https://doi.org/10.1016/j.lanhl.2025.100742 PMID:40845891
16. Cordova R, Viallon V, Fontvieille E, Peruchet-Noray L, Jansana A, Wagner KH, et al. (2023). Consumption of ultra-processed foods and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. Lancet Reg Health Eur. 35:100771. https://doi.org/10.1016/j.lanepe.2023.100771 PMID:38115963
17. Breeur M, Atkins J, Peruchet-Noray L, Bonheme L, Alcala N, Dossus L, et al. (2026). Autoencoders reveal polyunsaturated fatty acids (PUFA)-related metabolic signature linked to cancer risk. EBioMedicine. 106147. https://doi.org/10.1016/j.ebiom.2026.106147 PMID:41637936
18. Gan Q, Freisling H, Peruchet-Noray L, Fontvieille E, Matta K, Zhai Y, et al. (2025). Adiposity, mortality, and disease risk: insights from bioimpedance analysis and magnetic resonance imaging. BMC Med. 23(1):550. https://doi.org/10.1186/s12916-025-04356-9 PMID:41074136
19. Ebrahimi E, Naudin S, Dimou N, Mayén AL, Wang M, Abnet CC, et al. (2025). Alcohol consumption and upper aerodigestive tract squamous cell carcinoma: evidence from 28 prospective cohorts. J Natl Cancer Inst. 117(12):2598–611. https://doi.org/10.1093/jnci/djaf230 PMID:40977057
20. Matta K, Viallon V, Chatziioannou AC, Robinot N, Wedekind R, Dahm CC, et al. (2025). Can serum metabolic signatures inform on the relationship between healthy lifestyle and colon cancer risk? Cancer Metab. 13(1):30. https://doi.org/10.1186/s40170-025-00388-0 PMID:40524238